tyrosine has been researched along with lisinopril in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abdul Jabbar, M; Kasturi, S; Sen, GC; Sen, I | 1 |
Hettiarachchi, J; Ramsay, LE; Wallis, EJ | 1 |
Allen, MJ; Hartford, C; Lee, A; Middlemost, S; Norton, GR; Trifunovic, B; Woodiwiss, AJ | 1 |
Nathisuwan, S; Talbert, RL | 1 |
1 review(s) available for tyrosine and lisinopril
Article | Year |
---|---|
A review of vasopeptidase inhibitors: a new modality in the treatment of hypertension and chronic heart failure.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Dose-Response Relationship, Drug; Heart Failure; Humans; Hypertension; Lisinopril; Mesylates; Natriuretic Peptide, Brain; Neprilysin; Pyridines; Randomized Controlled Trials as Topic; Thiazepines; Tyrosine | 2002 |
2 trial(s) available for tyrosine and lisinopril
Article | Year |
---|---|
Combined inhibition of neutral endopeptidase and angiotensin-converting enzyme by sampatrilat in essential hypertension.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Female; Guanosine Monophosphate; Humans; Hypertension; Lisinopril; Male; Mesylates; Middle Aged; Neprilysin; Renin; Tyrosine | 1998 |
Sustained antihypertensive actions of a dual angiotensin-converting enzyme neutral endopeptidase inhibitor, sampatrilat, in black hypertensive subjects.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Black People; Blood Pressure; Double-Blind Method; Enzyme Inhibitors; Female; Heart Rate; Hormones; Humans; Hypertension; Lisinopril; Male; Mesylates; Middle Aged; Neprilysin; Tyrosine | 1999 |
1 other study(ies) available for tyrosine and lisinopril
Article | Year |
---|---|
Mutations in two specific residues of testicular angiotensin-converting enzyme change its catalytic properties.
Topics: Amino Acid Sequence; Angiotensin-Converting Enzyme Inhibitors; Animals; Binding Sites; Binding, Competitive; Gene Expression; Genetic Vectors; Glutamates; Glutamic Acid; HeLa Cells; Humans; Kinetics; Lisinopril; Lysine; Male; Mutagenesis; Peptidyl-Dipeptidase A; Phenylalanine; Point Mutation; Rabbits; Recombinant Proteins; Substrate Specificity; Testis; Transfection; Tyrosine; Vaccinia virus | 1993 |